Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer.
Studer G, Rordorf T, Glanzmann C. Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer. Radiat Oncol 2011; 6:120.
22.09.2011Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer.
22.09.2011Radiat Oncol 2011; 6:120
Studer Gabriela, Rordorf Tamara, Glanzmann Christoph
Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma
Saletti P, Sessa C, De Dosso S, Cerny T, Renggli V, Köberle D. Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma. Oncology 2011; 81:50-4.
15.09.2011Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma
15.09.2011Oncology 2011; 81:50-4
Saletti Piercarlo, Sessa Cristiana, De Dosso Sara, Cerny Thomas, Renggli Verena, Köberle Dieter
Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht
Müller-Westermann J, Traichel B, Hundsberger T, Eychmuller S, Tettenborn B (2011). Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht.
08.09.2011Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht
08.09.201184. DGN (Deutsche Gesellschaft für Neurologie) Jahreskongress, 2011
Müller-Westermann J, Traichel B, Hundsberger Thomas, Eychmuller S, Tettenborn Barbara
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial
Huober J, Nimmrich I, May C, Beckmann M, Baumgärtner A, Kubista E, Ragosch V, Azim H, Paepke S, Reimer T, Thomssen C, Wallwiener D, Petruzelka L, Barsoum M, Fasching P, Harbeck N. Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial. Breast 2011; 21:27-33.
08.09.2011Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial
08.09.2011Breast 2011; 21:27-33
Huober Jens, Nimmrich I, May C, Beckmann M W, Baumgärtner A K, Kubista E, Ragosch V, Azim H A, Paepke S, Reimer T, Thomssen C, Wallwiener D, Petruzelka L, Barsoum M, Fasching P A, Harbeck N
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
Chirgwin J, Coates A, Goldhirsch A, Regan M, Bonnefoi H, Ejlertsen B, Thürlimann B, Price K, Smith I, Sun Z, BIG 1-98 Collaborative and International Breast Cancer Study Groups. The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Res Treat 2011; 131:295-306.
04.09.2011The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
04.09.2011Breast Cancer Res Treat 2011; 131:295-306
Chirgwin Jacquie, Coates Alan S, Goldhirsch Aron, Regan Meredith M, Bonnefoi Hervé, Ejlertsen Bent, Thürlimann Beat, Price Karen N, Smith Ian, Sun Zhuoxin, BIG 1-98 Collaborative and International Breast Cancer Study Groups
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
Esserman L, van Leeuwen F, Linn S, Moore D, Glas A, Mook S, Retèl V, Knauer M, Rutgers E, Shieh Y, van 't Veer L. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 2011; 130:725-34.
04.09.2011Impact of mammographic screening on the detection of good and poor prognosis breast cancers
04.09.2011Breast Cancer Res Treat 2011; 130:725-34
Esserman Laura J, van Leeuwen Flora E, Linn Sabine, Moore Dan H, Glas Annuska M, Mook Stella, Retèl Valesca P, Knauer Michael, Rutgers Emiel J T, Shieh Yiwey, van 't Veer Laura J
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer
Stahel R, Thatcher N, Früh M, Le Péchoux C, Postmus P, Sorensen J, Felix E, Panel members. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. Ann Oncol 2011; 22:1973-1980.
01.09.20111st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer
01.09.2011Ann Oncol 2011; 22:1973-1980
Stahel R, Thatcher N, Früh Martin, Le Péchoux C, Postmus P E, Sorensen J B, Felix E, Panel members
The changing therapeutic landscape of castration-resistant prostate cancer
Yap T, Zivi A, Omlin A, de Bono J. The changing therapeutic landscape of castration-resistant prostate cancer. Nat Rev Clin Oncol 2011; 8:597-610.
09.08.2011The changing therapeutic landscape of castration-resistant prostate cancer
09.08.2011Nat Rev Clin Oncol 2011; 8:597-610
Yap Timothy A, Zivi Andrea, Omlin Aurelius, de Bono Johann S
Pyrazinamide-induced sideroblastic anemia
Colucci G, Silzle T, Solenthaler M. Pyrazinamide-induced sideroblastic anemia. Am J Hematol 2011; 87:305.
04.08.2011Pyrazinamide-induced sideroblastic anemia
04.08.2011Am J Hematol 2011; 87:305
Colucci Giuseppe, Silzle Tobias, Solenthaler Max
Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen
Baumann M. Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen. info@onkologie 2011:6-10.
01.08.2011Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen
01.08.2011info@onkologie 2011:6-10
Baumann Michael
[Intra-abdominal inflammation and perforation]
Gass M, Gueller U. [Intra-abdominal inflammation and perforation]. Ther Umsch 2011; 68:473-7.
01.08.2011[Intra-abdominal inflammation and perforation]
01.08.2011Ther Umsch 2011; 68:473-7
Gass Markus, Gueller Ulrich
[Abdominal pain - differential diagnoses and diagnostic strategies in patients with chronic symptoms]
Gueller U, Macpherson A. [Abdominal pain - differential diagnoses and diagnostic strategies in patients with chronic symptoms]. Ther Umsch 2011; 68:459-62.
01.08.2011[Abdominal pain - differential diagnoses and diagnostic strategies in patients with chronic symptoms]
01.08.2011Ther Umsch 2011; 68:459-62
Gueller Ulrich, Macpherson Andrew J
[Abdominal pain without any identifiable cause: a guide for the general practitioner]
Fahrner R, Gueller U. [Abdominal pain without any identifiable cause: a guide for the general practitioner]. Ther Umsch 2011; 68:456-8.
01.08.2011[Abdominal pain without any identifiable cause: a guide for the general practitioner]
01.08.2011Ther Umsch 2011; 68:456-8
Fahrner René, Gueller Ulrich
Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib
Baumann M, Cerny T, Sommacal A, Köberle D. Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib. Hematol Oncol 2011
05.07.2011Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib
05.07.2011Hematol Oncol 2011
Baumann Michael, Cerny Thomas, Sommacal Andreas, Köberle Dieter
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group
Baumann K, Lück H, Vergote I, Schmalfeldt B, Huober J, Sehouli J, Loibl S, du Bois A, Kurzeder C, Burchardi N, Wimberger P, Pfisterer J, Wagner U. Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group. Gynecol Oncol 2011; 123:27-32.
05.07.2011Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group
05.07.2011Gynecol Oncol 2011; 123:27-32
Baumann K, Lück H J, Vergote I, Schmalfeldt B, Huober Jens, Sehouli J, Loibl S, du Bois A, Kurzeder C, Burchardi N, Wimberger P, Pfisterer J, Wagner U
Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring
Skipworth R, Helbostad J, Fearon K, Preston T, Strasser F, Radbruch L, Trottenberg P, Kaasa S, Blum D, Small A, Hendry P, Dahele M, Stene G, European Palliative Care Research Collaborative (EPCRC). Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring. Clin Nutr 2011; 30:812-21.
05.07.2011Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring
05.07.2011Clin Nutr 2011; 30:812-21
Skipworth Richard J E, Helbostad Jorunn L, Fearon Kenneth C H, Preston Tom, Strasser Florian, Radbruch Lukas, Trottenberg Peter, Kaasa Stein, Blum David, Small Alexandra C, Hendry Paul O, Dahele Max, Stene Guro B, European Palliative Care Research Collaborative (EPCRC)
[Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations]
Hartmann M, Krege S, Souchon R, De Santis M, Gillessen Sommer S, Cathomas R, Interdisziplinäre Arbeitsgruppe Hodentumore. [Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations]. Urologe A 2011; 50:830-5.
01.07.2011[Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations]
01.07.2011Urologe A 2011; 50:830-5
Hartmann M, Krege S, Souchon R, De Santis M, Gillessen Sommer Silke, Cathomas R, Interdisziplinäre Arbeitsgruppe Hodentumore
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome
Kaelin M, Krek W, Aebersold R, Cerny T, Templeton A, Wild P, Powles T, Fankhauser N, Schiess R, Cima I, Gillessen Sommer S. Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. Eur Urol 2011; 60:1235-43.
29.06.2011Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome
29.06.2011Eur Urol 2011; 60:1235-43
Kaelin Martin, Krek Wilhelm, Aebersold Ruedi, Cerny Thomas, Templeton Arnoud, Wild Peter, Powles Tom, Fankhauser Niklaus, Schiess Ralph, Cima Igor, Gillessen Sommer Silke
Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience
Früh M, Kacsir B, ess s, Cerny T, Rodriguez R, Plasswilm L. Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience. Strahlenther Onkol 2011; 187:561-7.
27.06.2011Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience
27.06.2011Strahlenther Onkol 2011; 187:561-7
Früh Martin, Kacsir Bela, ess silvia, Cerny Thomas, Rodriguez Regulo, Plasswilm Ludwig
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
Goldhirsch A, Wood W, Coates A, Gelber R, Thürlimann B, Senn H, Panel members. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22:1736-47.
27.06.2011Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
27.06.2011Ann Oncol 2011; 22:1736-47
Goldhirsch A, Wood W C, Coates A S, Gelber R D, Thürlimann Beat, Senn H-J, Panel members